Our analysis using the UALCAN database, however, showed that CAT expression was more variable in pancreatic and colorectal carcinoma patients, while the NFE2L2 expression was very similar between the three types of tumors (Supplementary Materials Figure S3A,B). The gene discussed is NFE2L2; the disease is colorectal carcinoma.